Crossmark

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction

Crossref DOI link: https://doi.org/10.1007/s13238-020-00803-w

Published Online: 2020-11-18

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fu, Wenyu

Chen, Yujianan

Wang, Kaidi

Hettinghouse, Aubryanna

Hu, Wenhuo

Wang, Jing-Quan

Lei, Zi-Ning

Chen, Zhe-Sheng

Stapleford, Kenneth A. https://orcid.org/0000-0002-7796-2254
Liu, Chuan-ju https://orcid.org/0000-0002-7181-8032
License Information

Text and Data Mining valid from 2020-11-18

Version of Record valid from 2020-11-18
More Information

Article History

Accepted: 18 September 2020

First Online: 18 November 2020